Radioiodine imaging (WBS) and serum thyroglobulin(TG) in management of thyroid cancer (DTC): Randomised study with recombinant human TSH (rhTSH) and without thyroid hormone

被引：0
|
作者：
Bertolazzi, L
Zoccola, R
Giusti, M
Villa, G
Scattina, M
机构：
[1] Univ Genoa, Dept Nucl Med, Genoa, Italy
[2] Univ Genoa, DISEM, Genoa, Italy
[3] Univ Genoa, DIMI, Genoa, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 2001年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PS520
引用
收藏
页码：1209 / 1209
页数：1
相关论文
共 50 条
  • [1] Ablation of differentiated thyroid cancer (DTC) with recombinant human TSH (rhTSH): a comparison between 1850 MBq and 3700 MBq of radioiodine
    Capoccetti, F.
    Pacini, F.
    Vattimo, A.
    Berbellini, A.
    Cidda, C.
    Fattori, S.
    Ferretti, F.
    Rossi, G.
    Sivolella, S.
    Pilli, T.
    Guarino, E.
    Burroni, L.
    Castagna, M. G.
    Cipri, C.
    Brianzoni, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S160 - S160
  • [2] Thyroglobulin (Tg) response to multiple rhTSH-aided radioiodine treatments (rhTSH-RITs) in patients with advanced differentiated thyroid carcinoma (DTC)
    Handkiewicz-Junak, Daria
    Marlowe, Robert
    Roskosz, Jozef
    Hasse-Lazar, Kornelia
    Szpak-Ulczok, Sylwia
    Jarzab, Barbara
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [3] Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH
    Sugino, Kimintori
    Ito, Koichi
    Takami, Hiroshi
    [J]. ENDOCRINE JOURNAL, 2006, 53 (06) : 723 - 728
  • [4] Thyroid radioiodine kinetics modification following recombinant human TSH (rhTSH) administration in multinodular goiter
    Bagnara, M. C.
    Calamia, I.
    Caorsi, V.
    Schiavo, M.
    Pomposelli, E.
    Reitano, C.
    Caputo, M.
    Giusti, M.
    Bagnasco, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S339 - S340
  • [5] Radioiodine thyroid remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC): Impact of recombinant human thyroid-stimulating hormone (rhTSH) on treatment room length-of-stay and utilization
    Antonio Vallejo, Juan
    Mena, Luisa
    Angeles Galvez, Maria
    Marlowe, Robert
    Latre, Jose
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [6] Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer
    Pacini, Furio
    Castagna, Maria Grazia
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (06) : 1009 - 1021
  • [7] Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer
    Durski, JM
    Weigel, RJ
    McDougall, IR
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (06) : 521 - 528
  • [8] Use of recombinant human thyroid-stimulating hormone (rhTSH) reduces the damage to salivary glands after radioiodine therapy for thyroid cancer
    Isoda, Takuro
    Baba, Shingo
    Maruoka, Yasuhiro
    Kitamura, Yoshiyuki
    Sasaki, Masayuki
    Honda, Hiroshi
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [9] Thyroid cancer and ablative radioiodine treatment after rhTSH stimulation : When serum thyroglobulin level be evaluated?
    Morel, O.
    Girault, S.
    Berthelot, C.
    Giraud, P.
    Jeanguillaume, C.
    Jallet, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S353 - S354
  • [10] Recombinant human TSH (rTSH) stimulated thyroglobulin (TG) levels and diagnostic iodine-131 whole body scanning (WBS) in the management of children with thyroid carcinoma
    Hoe, FM
    Charron, M
    Thomas, M
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 143A - 143A
12345